ONO PHARMA partners with Bristol Myers SquibbBristol-Myers Squibb ( BMY ), Bayer and Ono Pharmaceutical (OPHLY) have entered into a clinical collaboration agreement to evaluate the combination of Bayer's kinase inhibitor Stivarga and Bristol-Myers Squibb's / Ono's anti-PD-1 immune checkpoint inhibitor, Opdivo in patients with micro-satellite s
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.00 USD
845.55 M USD
3.32 B USD
328.10 M
About ONO PHARMACEUTICAL CO
Sector
Industry
CEO
Gyo Sagara
Website
Headquarters
Osaka
Founded
1947
ISIN
JP3197600004
FIGI
BBG000D1Y479
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.
ONO PHARMA partners with Bristol Myers SquibbTODAY'S ANNOUNCEMENT
Bristol-Myers Squibb (BMY), Bayer and Ono Pharmaceutical (OPHLY) have entered into a clinical collaboration agreement to evaluate the combination of Bayer's kinase inhibitor Stivarga and Bristol-Myers Squibb's / Ono's anti-PD-1 immune checkpoint inhibitor, Opdivo in patients wi
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of OPHLF is 11.81 USD — it has increased by 0.94% in the past 24 hours. Watch Ono Pharmaceutical Co., Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Ono Pharmaceutical Co., Ltd. stocks are traded under the ticker OPHLF.
OPHLF stock has risen by 14.49% compared to the previous week, the month change is a 5.59% rise, over the last year Ono Pharmaceutical Co., Ltd. has showed a −26.00% decrease.
We've gathered analysts' opinions on Ono Pharmaceutical Co., Ltd. future price: according to them, OPHLF price has a max estimate of 17.52 USD and a min estimate of 9.81 USD. Watch OPHLF chart and read a more detailed Ono Pharmaceutical Co., Ltd. stock forecast: see what analysts think of Ono Pharmaceutical Co., Ltd. and suggest that you do with its stocks.
OPHLF reached its all-time high on Dec 18, 2015 with the price of 174.00 USD, and its all-time low was 9.22 USD and was reached on Jan 30, 2025. View more price dynamics on OPHLF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
OPHLF stock is 8.80% volatile and has beta coefficient of 0.39. Track Ono Pharmaceutical Co., Ltd. stock price on the chart and check out the list of the most volatile stocks — is Ono Pharmaceutical Co., Ltd. there?
Today Ono Pharmaceutical Co., Ltd. has the market capitalization of 5.62 B, it has increased by 3.27% over the last week.
Yes, you can track Ono Pharmaceutical Co., Ltd. financials in yearly and quarterly reports right on TradingView.
Ono Pharmaceutical Co., Ltd. is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
OPHLF earnings for the last quarter are 0.20 USD per share, whereas the estimation was 0.27 USD resulting in a −23.96% surprise. The estimated earnings for the next quarter are 0.15 USD per share. See more details about Ono Pharmaceutical Co., Ltd. earnings.
Ono Pharmaceutical Co., Ltd. revenue for the last quarter amounts to 853.66 M USD, despite the estimated figure of 833.85 M USD. In the next quarter, revenue is expected to reach 810.44 M USD.
OPHLF net income for the last quarter is 95.01 M USD, while the quarter before that showed 117.30 M USD of net income which accounts for −19.00% change. Track more Ono Pharmaceutical Co., Ltd. financial stats to get the full picture.
Ono Pharmaceutical Co., Ltd. dividend yield was 3.26% in 2023, and payout ratio reached 30.01%. The year before the numbers were 2.53% and 30.32% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 24, 2025, the company has 3.85 K employees. See our rating of the largest employees — is Ono Pharmaceutical Co., Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ono Pharmaceutical Co., Ltd. EBITDA is 714.64 M USD, and current EBITDA margin is 36.15%. See more stats in Ono Pharmaceutical Co., Ltd. financial statements.
Like other stocks, OPHLF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ono Pharmaceutical Co., Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ono Pharmaceutical Co., Ltd. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Ono Pharmaceutical Co., Ltd. stock shows the sell signal. See more of Ono Pharmaceutical Co., Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.